Coya Therapeutics, Inc.
Coya Therapeutics, Inc. scores highest on Torque (65) and lowest on Price (26). Its PosiPenta is 45.28 out of 100, around the middle of similar companies.
On the Penta Grid this week, Coya Therapeutics, Inc. is Grid #375 of 837 in the Healthcare sector in United States, and Grid #2,386 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Coya Therapeutics, Inc. | 45.28 | 26 | 28 | 49 | 65 | 58 |
| Polaryx Therapeutics, Inc. | 40.50 | 8 | 72 | 4 | 59 | 60 |
| Anixa Biosciences, Inc. | 41.53 | 11 | 46 | 42 | 55 | 54 |
| Park Dental Partners, Inc. | 51.60 | 22 | 73 | 73 | 37 | 54 |
| Vivani Medical, Inc. | 34.40 | 13 | 45 | 53 | 16 | 45 |
| Immunic, Inc. | 39.67 | 43 | 33 | 40 | 51 | 33 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.97 |
| P/B ratio | 2.30 |
EEarnings
| Trailing EPS | ₹-101.34 |
| Forward EPS | ₹-181.85 |
NNitro
| Price | 402.54 |
| 52-week high | 715.10 |
| 52-week low | 351.39 |
| Fall from 52-week high | 43.7% |
TTorque
| Return on equity (ROE) | -60.54% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.58 |
| Market cap | ₹944 Cr |
| Insider holding | 14.69% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Coya Therapeutics, Inc.'s PosiPenta score?
Coya Therapeutics, Inc.'s PosiPenta is 45.28 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Coya Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Coya Therapeutics, Inc. is Grid #375 of 837 in the Healthcare sector in United States, and Grid #2,386 of 4,000 in United States.
Which PosiPenta pillar is strongest for Coya Therapeutics, Inc.?
Torque (durability), with a score of 65 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Coya Therapeutics, Inc.?
Price (valuation), with a score of 26 out of 100: weaker than most similar companies.
Has Coya Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.15 points, from 41.13 to 45.28.
PositoAI is for research and education only and is not investment advice.